Stock listing
NASDAQ:ONCT Oncternal Therapeutics Inc Stock
Follow Oncternal Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ONCT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ONCT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Oncternal Therapeutics Inc on 6ix
- Calls
- 11 calls with a replay · 11 with a transcript · latest Aug 8, 2024
Events
| Call | When | Status |
|---|---|---|
| Oncternal Therapeutics (ONCT) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2024 Earnings Call | Thu, May 09, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q4 2023 Earnings Call | Thu, Mar 07, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2023 Earnings Call | Thu, May 04, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q3 2022 Earnings Call | Thu, Nov 03, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2022 Earnings Call | Thu, May 05, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q4 2021 Earnings Call | Thu, Mar 10, 2022 · 5:00 PM ET | Replay |
All 11 calls
| Call | When | Status |
|---|---|---|
| Oncternal Therapeutics (ONCT) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 5:00 PM ET | Replay |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rosemary Mazanet Other companies: Kairos Pharma, Ltd. (Director · Sep 16, 2024 – Sep 16, 2024 · Past); Actinium Pharmaceuticals, Inc. (Delaware) (Director · Dec 28, 2012 – May 15, 2013 · Past); SELLAS Life Sciences Group, Inc. (Chief Medical Officer · Feb 1, 2012 – Jan 29, 2013 · Past); Abeona Therapeutics Inc. (Director · Jan 4, 2007 – Jan 4, 2007 · Past); Aksys Ltd (Director · Aug 9, 2006 – Oct 24, 2006 · Past) | Director · Jan 1, 2006 – Jun 20, 2024 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past) | Director · Jun 7, 2019 – Jun 20, 2024 · Past |
| James Breitmeyer Other companies: Vaxart, Inc. (Director · Since at least Apr 23, 2026); Otonomy Inc (Director · Jun 19, 2018 – Jun 21, 2022 · Past); Zogenix Inc (Director · Jul 13, 2016 – Mar 7, 2022 · Past) | Chief Executive Officer, Director · Jun 7, 2019 – Feb 14, 2024 · Past |
| Chase C Leavitt Other companies: Mobia Medical, Inc. (SEE REMARKS · Since at least May 7, 2026); Lineage Cell Therapeutics, Inc. (General Counsel/Secretary · May 20, 2019 – Mar 15, 2021 · Past) | General Counsel/Secretary · May 25, 2021 – Feb 14, 2024 · Past |
| Daniel L Kisner Other companies: Dynavax Technologies Corporation (Director · Since at least May 23, 2024); Zynerba Pharmaceuticals Inc (Director · Oct 10, 2023 – Oct 10, 2023 · Past) | Director · Jun 20, 2024 – Jun 20, 2024 · Past |
| Robert Wills Other companies: Alpha Cognition Inc. (Chairman · Since at least Apr 7, 2025); Milestone Pharmaceuticals Inc. (Director · Since at least Oct 1, 2020) | Director · Mar 2, 2015 – Jun 20, 2024 · Past |
| William R Larue Other companies: Histogen Inc (Director · Feb 6, 2017 – Jun 27, 2019 · Past); Cadence Pharmaceuticals Inc (SVP, CFO, Treas, Asst Sec · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Jun 7, 2019 – Jun 20, 2024 · Past |
| Charles Theuer Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020) | Director · Jun 7, 2019 – Jun 20, 2024 · Past |
| Diane C. Young Other companies: Celldex Therapeutics, Inc. (Senior Vice President and Chief Medical Officer · Since at least Jul 8, 2019) | VP, Chief Medical Officer · Jul 13, 2015 – Jul 13, 2018 · Past |
| Frank J Hsu Other companies: Apexigen Inc. (Chief Medical Officer · Jul 29, 2022 – Aug 23, 2023 · Past) | Chief Medical Officer · Aug 26, 2019 – Mar 17, 2020 · Past |
All 22 people
| Person | Seat |
|---|---|
| Mitchell S. Steiner Other companies: Veru Inc. (Chairman, President, and Chief Executive Officer · Since at least Oct 31, 2016) | Chief Executive Officer, Director · Feb 24, 2006 – Jan 29, 2014 · Past |
| Richard G Vincent Other companies: Forte Biosciences, Inc. (Director · Since at least Sep 17, 2024) | Chief Financial Officer · Jun 7, 2019 – Feb 14, 2024 · Past |
| Andrew M Clarkson | Director · Jan 1, 2006 – Jun 30, 2008 · Past |
| Gunnar F Kaufmann | Chief Scientific Officer · Jul 28, 2022 – Jun 12, 2023 · Past |
| Henry Patton Doggrell | VP, Chief Legal Officer · Oct 1, 2013 – Jun 20, 2018 · Past |
| Jeffrey G Hesselberg | Vice President, Regulatory · May 15, 2007 – Jul 30, 2008 · Past |
| Jinzhu PhD Chen | Director · May 25, 2021 – Jun 16, 2022 · Past |
| Kenneth S Robinson | Director · Sep 30, 2008 – Oct 1, 2018 · Past |
| Mark Edward Mosteller | Vice President, CFO · May 12, 2006 – Jul 8, 2013 · Past |
| Rajesh Krishnan | CTO/CSO · Jul 28, 2022 – Feb 14, 2024 · Past |
| Salim Yazji | Chief Medical Officer · Oct 2, 2023 – Feb 14, 2024 · Past |
| Xin Nakanishi | Director · Jun 7, 2019 – Jun 28, 2023 · Past |
Log in to ask 6ix AI your own questions about Oncternal Therapeutics Inc.